CClinicalTrials.gg
RecruitingNCT03981107TANGO2Updated May 8, 2026

Compression Only CPR Versus Standard CPR in Out-Of-Hospital Cardiac Arrest - A Randomized Survival Study

An interventional study of Chest Compression Only CPR (CO-CPR) performed by trained bystanders after instructions from dispatchers and Standard CPR (S-CPR) performed by trained bystanders after instructions from dispatchers in Out-Of-Hospital Cardiac Arrest, Cardiac Arrest and Cardiopulmonary Resuscitation, sponsored by Karolinska Institutet. Recruiting at 2 sites in 2 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-08.

Sponsored by Karolinska Institutet · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 5 months after the study started (first participant enrolled Jan 2017, registered Jun 2019).
  • Started Jan 2017; still recruiting 9 years 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
3,260
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Out-of-hospital cardiac arrest (OHCA) is one of the leading causes of mortality in the industrialized world. Bystander CPR before arrival of the Emergency Medical Service (EMS) is associated with an increased chance of survival.

During the last decade, the best form of bystander CPR has been debated. Chest Compression Only CPR (CO-CPR) has been advocated as a preferable method in situations where the bystander has no previous knowledge in CPR, both because its believed to be equally efficient but also a simplified form of CPR that could lead to a higher incidence of bystander-CPR.

In an initiative to increase CPR rates the American Heart Association has launched public campaigns such as the "hands-only CPR" promoting CO-CPR as an option to S-CPR for adult non-asphyxic cardiac arrest. In the 2015 updates of the European resuscitation council guidelines it states that the confidence in the equivalence between the two methods is not sufficient to change current practice.

Whether CO-CPR leads to a survival rate no worse than, or even superior to standard CPR in situations where the bystander has previous CPR training remains unclear. This clinical question remains unanswered while millions of people are trained in CPR worldwide each year.

To investigate whether CO-CPR is non-inferior to standard CPR (S-CPR) when performed by a bystander with previous CPR training in witnessed, non-asphyxic cases of OHCA. Superiority testing will also be performed for the purpose of demonstrating a possible increase in survival with CO-CPR.

Read the detailed description

This is an interventional, prospective, randomized, 1:1 open label, multicenter trial comparing two different methods of bystander CPR in witnessed cases of OHCA. Since CO-CPR is a simplified form of CPR that could lead to a higher rate of bystander-CPR by itself, a non-inferiority design for the primary outcome has been chosen. Superiority testing will also be performed to demonstrate a potential increase in survival with CO-CPR.

Witnessed cases of OHCA with a non-asphyctic aetiology will be the principal study population. According to current guidelines, an unresponsive patient with no or agonal breathing is treated as a suspected case of OHCA at the dispatch centre. These cases are eligible for screening for inclusion. If the case is witnessed, the bystander has previous knowledge in CPR, and no exclusion criteria are present, the case can be included in the study. If included, it will be randomly assigned to either CO-CPR (intervention) or S-CPR (control).

The intervention consists of instructions from a dispatcher at the dispatch center to bystanders to perform either CO-CPR (intervention) or S-CPR (control).

  • Instructions to bystanders on how to perform CO-CPR include continuous chest compressions without interruptions or rescue breaths.
  • Instructions to bystanders on how to perform S-CPR in the control group include information on giving chest compressions and rescue breaths in a 30:2 ratio.

This is a national study where all dispatch centers in Sweden participate, and since 2025, selected sites in northern Italy.

The overall study project is conducted in three different phases:

  1. RUN-IN period, for establishing logistical and technical study procedures (completed)
  2. PILOT STUDY, with focus on feasibility, logistics, and safety (completed)
  3. MAIN STUDY will focus on 30-day survival (primary end point) and other important clinical outcomes (secondary outcomes)

Objective for RUN-IN period:

In order to test the technical inclusion procedures, logistics, feasibility, and data collection, a pre-study RUN-IN period started in Stockholm during 2015.

Objective PILOT study:

The PILOT study aimed to assess the safety and feasibility of the TANGO2 trial design, as well as intermediate clinical outcomes. The TANGO2 trial started recruitment of patients on January 1st, 2017, and the last patient was included on December 31st, 2018. All patients from the PILOT study will be included in the MAIN STUDY in a seamless design.

Objective MAIN study:

The MAIN study aims to evaluate whether survival to 30 days following instructions to perform CO-CPR is non-inferior to instructions to perform S-CPR in witnessed OHCA where the bystander has previous CPR training.

02

Conditions studied

  • Out-Of-Hospital Cardiac Arrest
  • Cardiac Arrest
  • Cardiopulmonary Resuscitation

Keywords

  • Cardiopulmonary Resuscitation
  • Chest compressions only CPR
  • Dispatcher assisted CPR
  • Cardiac Arrest
03

In context

Out-of-Hospital Cardiac Arrest

323 studies on the registry are indexed under Out-of-Hospital Cardiac Arrest; 89 are open to participants now.

This study's planned enrollment of 3,260 is above the median of 218 across 183 interventional studies indexed under Out-of-Hospital Cardiac Arrest.

Browse Out-of-Hospital Cardiac Arrest studies →

Lead sponsor

Karolinska Institutet is the lead sponsor of 1,113 studies on the registry; 267 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Unconsciousness with no, abnormal or agonal breathing (suspected OHCA)
  • The suspected OHCA is witnessed (seen or heard)
  • Any Bystander at the scene has previous training in CPR

Exclusion criteria

Exclusion Criteria:

  • Age below 18 years
  • Collapse is not witnessed
  • Bystander has no prior CPR training
  • Obvious asphyxia (i.e. hanging, foreign body, suffocation, strangulation)
  • Obvious drug overdose / intoxication
  • Pregnancy
  • Trauma (penetrating, blunt, burn injury)

Post randomisation exclusion Criteria from data analysis:

  • Not EMS-verified cardiac arrest
  • Previous do not resuscitate (DNR) decision
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
3,260 participants (estimated)

Study arms

  • Experimental
    Chest Compression Only CPR (CO-CPR)

    Instructions from a dispatcher at the dispatch center to trained bystanders to perform CO-CPR with chest compressions only.

    Other: Chest Compression Only CPR (CO-CPR) performed by trained bystanders after instructions from dispatchers

  • Active comparator
    Standard CPR (S-CPR)

    Instructions from a dispatcher at the dispatch center to trained bystanders to perform S-CPR with chest compressions and rescue breaths in a 30:2 ratio.

    Other: Standard CPR (S-CPR) performed by trained bystanders after instructions from dispatchers

Interventions

  • OtherChest Compression Only CPR (CO-CPR) performed by trained bystanders after instructions from dispatchers

    Instructions by dispatcher to bystander to provide CPR with chest-compressions only The instructions from the dispatcher in interventional arm include: * An ambulance is dispatched and is on it´s way to you * Do CPR with chest compressions only * Push hard on the chest with a pace of 100/minute without interruptions for rescue breathing.

    Also known as: Chest compression only CPR, Compression only CPR, Hands-only CPR

  • OtherStandard CPR (S-CPR) performed by trained bystanders after instructions from dispatchers

    Instructions by dispatcher to bystander to provide CPR with chest-compressions and rescue breaths in a ration of 30:2 The Instructions from the dispatcher in the control arm include: * An ambulance is dispatched and is on it´s way to you * Do CPR with chest compressions and rescue breathing * Push hard on the chest 30 times and give 2 rescue breaths. The pace of the compressions should be 100/minute.

    Also known as: Standard CPR

06

What researchers measure

Primary outcomes

  1. 30-day survival

    Survival to 30 days after cardiac arrest

    Time frame: 1 month

Secondary outcomes

  1. 1-day survival

    1-day survival will be derived from the date of death recorded in Swedish Cardiopulmonary Resuscitation Registry (SRCR). Because SRCR only provides the calendar date of death (and not the exact time), we cannot reliably determine the Utstein variable "survival to hospital admission". We therefore will use 1-day survival as a proxy. If the SRCR date of death is the calendar day after the event date, the patient will be classified as still alive after 1-day. Separating survival to hospital admission from early in-hospital death will not be possible with the available SRCR data.

    Time frame: 1 day

  2. 1-year survival

    Survival to 1-year after cardiac arrest

    Time frame: 1 year

  3. Survival with good neurologic outcome at discharge

    Survival to hospital discharge with cerebral performance category (CPC) 1-2

    Time frame: 30 days

Other outcomes

  1. Proportion of participants found with VT/VF at first rhythm analysis

    Proportion of participants found with ventricular tachycardia (VT) or ventricular fibrillation (VF) at first rhythm analysis by the EMS or by an automated external defibrillator (AED)

    Time frame: 1 day

  2. Proportion of participants with return of spontaneous Circulation (ROSC)

    Proportion of participants with return of spontaneous Circulation

    Time frame: 1 day

  3. Analysis of primary endpoint (30-day survival) in pre-defined subgroup

    Subgroups will be analysed according to the following pre-defined variables: Sex, Age, Cause of OHCA, Initial rhythm, Location of cardiac arrest, Time to start of bystadner CPR, Time to arrival of EMS and Neurological severity classification (CPC).

    Time frame: 30 days

07

Study locations

2 of 2 sites recruiting
  • AREU, Agenzia Regionale Emergenza Urgenza
    Bergamo, Italy
    Recruiting
  • SOS Alarm AB
    Stockholm, Sweden
    Recruiting
08

References and documents

Study documents

  • Protocol and statistical analysis plan · Dec 20, 2025

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — Data will be published on group level only

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03981107
Lead sponsor
Karolinska Institutet
Collaborators
Swedish Heart Lung Foundation, SOS Alarm, Azienda Regionale Emergenza Urgenza - AREU Lombardia, The Swedish Research Council
Responsible party
Jacob Hollenberg (Professor, Head of research - Centre For Resuscitation Science., Karolinska Institutet) — Principal investigator
First posted
Jun 10, 2019
Start date
Jan 1, 2017
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
May 8, 2026

Study contacts

Jacob Hollenberg, MD. PhD
Contact
jacob.hollenberg@ki.se
004686163816
Jacob Hollenberg, MD, PhD
principal investigator · Karolinska Institutet
Giuseppe Ristagno, MD, PhD
study chair · University of Milan
Gabril Riva, MD, PhD
study chair · Karolinska Institutet
Martin Jonsson, McS, PhD
study chair · Karolinska Institutet
Mattias Ringh, MD, PhD
study chair · Karolinska Institutet
Per Nordberg, MD, PhD
study chair · Karolinska Institutet
Annette Nord, RN, PhD
study chair · Karolinska Institutet
Andreas Claesson, RN, PhD
study chair · Karolinska Institutet
Marcus Skrifvars, MD, PhD
study chair · University of Helsinki

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion